权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Effects of Age-Related Changes in the Microenvironment on Patterns of Hematopoiesis

与年龄相关的微环境变化对造血模式的影响

基本信息

批准号：
9364678
负责人：
KENNETH Allan DORSHKIND
金额：
$ 31.78万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-15 至 2022-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9364678
关键词：
Active Sites Adipocytes Affect Age Aging Alpha Cell Animals Antibodies B cell repertoire B-Cell Development Birth Blood Cells Bone Marrow Cells Complement Data Development Elderly Gene Expression Profile Generations Genetic Models Goals Hematopoiesis Hematopoietic Hematopoietic stem cells High Fat Diet Immune system Immunity Immunoglobulin-Secreting Cells Impairment In Vitro Individual Infection Inflammation Mediators Inflammatory Interleukin-1 Interleukin-1 Receptors Intervention Life Light Literature Lymphocyte Lymphoid Lymphoid Cell Lymphopoiesis Measures Modeling Mus Myelogenous Myeloid Cells Myelopoiesis Pattern Peroxisome Proliferator-Activated Receptors Pharmaceutical Preparations Pharmacology Plasma Cells Population Predisposition Process Production Red Marrow Rejuvenation Resistance Signal Transduction Source Stromal Cells System Testing Time Vaccination Yellow Marrow age effect age related cohesion cytokine environmental change expectation experimental study impaired capacity in vivo insight interest novel prevent response transcriptome

项目摘要

Abstract Hematopoiesis is often viewed as a uniform process in which lymphoid and myeloid cells are continually generated in constant proportions throughout life. It is now evident that this is not the case and that, with increasing age, there is a decline in B cell development while myelopoiesis remains relatively intact. This in turn is thought to contribute to the increased susceptibility of the elderly to infection and the reduced efficacy of vaccination. The central hypothesis of this proposal is that the age-related accumulation of adipocytes and plasma cells in the medullary cavity impairs the capacity of the hematopoietic microenvironment to support lymphopoiesis. In contrast, myelopoiesis is either resistant to or is stimulated by these changing environmental dynamics. At birth most of the bone marrow is referred to as “red” marrow to indicate that it is a site of active hematopoiesis. However, with increasing age there is an accumulation of adipocytes and the formation of non- hematopoietic “yellow” marrow. The accumulation of bone marrow adipocytes is a gradual process, and we propose that as this occurs, lymphopoiesis is preferentially inhibited while myelopoiesis remains relatively intact. Experiments in Aim 1 will test this hypothesis using both in vivo and in vitro systems, and we will also analyze patterns of hematopoiesis in PPAR-γ+/– mice, which have a highly significant diminution in bone marrow adipocytes, over time. The expectation is that age-related declines in B lymphopoiesis will be less severe in this strain due to their adipocyte deficiency. Bone marrow adipocytes provide a supportive niche for plasma cells. In view of their increase in number with age, we considered the possibility that plasma cells might also increase over time and found this to be the case. This has significant implications, as plasma cells are a source of numerous inflammatory cytokines known to inhibit B lymphopoiesis. Experiments in Aim 2 will test the hypothesis that this increase in plasma cells also contributes to age-related reductions in lymphocyte development. We will build upon preliminary data showing that plasma cells co-localize with hematopoietic stem cells (HSCs) in the bone marrow and evaluate the potential of plasma cell derived signals to skew the developmental potential of HSCs towards myelopoiesis. We will also generate Cd19-Cre;flPrdm1fl mice which lack plasma cells and determine if declines in B lymphopoiesis in these animals are less precipitous over time. A key question from a translational perspective is whether lymphopoiesis can be rejuvenated in old individuals. The experiments in Aim 3 will test the ability of various interventions, which include drugs that inhibit adipocyte formation and antibodies that deplete plasma cells, to rejuvenate B lymphopoiesis in the elderly. Additional experiments will determine if these interventions target HSCs and affect patterns of gene expression in them. Taken together, the data obtained in the proposed studies will increase the understanding of how aging affects hematopoiesis and identify interventional targets that may have translational potential for rejuvenating immunity in the elderly.

摘要